A study identifies motor delay and hypotonia as key predictors of genetic diagnoses, aiding clinicians in neurodevelopmental care and genetic testing decisions.
Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market – Biotech Investments
EQS-News: ABIVAX / Key word(s): IPO Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market 20.10.2023 / 15:00 CET/CEST The